Melatonin Supplementation to Improve Sleep in Patients With Heart Failure

• Status: Withdrawn
• Trial end date: 2011-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether melatonin can improve sleep, quality of life and markers of heart failure in patients with heart failure.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brigham and Women's Hospital
• Collaborator: American Academy of Sleep Medicine
• Treatments: Central Nervous System Depressants; Melatonin; Molecular Mechanisms of Pharmacological Action

Criteria

Inclusion Criteria:

• Diagnosed with heart failure NYHA Class 2 or 3

• Currently being treated with beta-blocker

Exclusion Criteria:

• Diagnosed with obstructive sleep apnea

• Using Fluvoxamine, Warfarin, Nifedipine, or Calcium Channel Blockers